Navigation Links
Actos Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Actos Bladder Cancer Litigation
Date:7/21/2013

New York, New York (PRWEB) July 21, 2013

Actos lawsuit claims involving allegations that the drug caused users to develop bladder cancer continue to move forward in a multidistrict litigation now underway in U.S District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to court documents, the Actos bladder cancer litigation’s next Status Conference has been scheduled for Thursday, July 25th. An update issued by the U.S. Judicial Panel on Multidistrict Litigation on July 10th indicated that more than 2,400 Actos lawsuits are now pending in the consolidated proceeding. (In re: Actos Product Liability Litigation, MDL No. 2299)

“We continue to hear from individuals seeking to file Actos lawsuits that allege the drug caused their bladder cancer. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to patients who developed the disease after using the medication for an extended period of time

Actos Bladder Cancer Lawsuits
Actos lawsuits pending in the Western District of Louisiana accuse Takeda Pharmaceuticals of concealing knowledge that use of the type 2 diabetes treatment was associated with an increased risk of bladder cancer, and failing to provide adequate warnings to patients and doctors regarding this risk. According to court documents, the first trial in the federal Actos litigation is scheduled to begin on January 27, 2014.

In April, the nation’s first trial involving Actos bladder cancer allegations ended with a Los Angeles Superior Court jury awarding $6.5 million to a plaintiff who was diagnosed with the disease after taking Actos for four yea
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
4. Researchers Offer Explanation for Actos Bladder Cancer Risk
5. New Lawsuit alleges Actos caused Bladder Cancer
6. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
11. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... Representatives with ... at the highly anticipated Mississippi Gulf Babypalooza on September 19, 2015. , “We ... from Gulfport, Biloxi, and beyond. We will be discussing setting up college funds, ...
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have seen an ... health care model, where the primary care physician dictates and the patient obeys. Instead, ... educated about their health issues and empowered to choose their own treatment options. , ...
(Date:9/3/2015)... ... September 03, 2015 , ... About 220,800 new cases of prostate cancer are reported each year, ... diagnosed with prostate cancer during their lifetime. While only one man in 10,000 will typically ... by age 65, according to the American Cancer Society. , Prostate ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will ... wellness. In this episode, James Earl Jones will introduce a segment that discusses why ... workplace and how workplace wellness can be fostered in any working environment. , Employers ...
(Date:9/3/2015)... FLORIDA (PRWEB) , ... September 03, 2015 , ... ... of the highest-regarded health professionals out there. His perspective on internal medicine keeps patients ... stay happy and healthy is important regardless of the season, but even more so ...
Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2
... Eli Lilly and Company (NYSE: LLY ) today declared a ... outstanding common stock. This is the same dividend as was paid ... rate for 2009 of $1.96 per share. , , The ... close of business on August 15, 2009. , , About Lilly ...
... blames physician misdiagnosis as the likely cause of apparent uptick ... A newly released study in the June 2009 British Journal ... the eastern United Kingdom has concluded that the much-hyped melanoma ... The study attributed the increase in melanoma diagnoses to heightened ...
... Now there,s a new reason for the,weight-conscious to drink fat ... the July issue of the American Journal of Clinical,Nutrition. Researchers ... helped increase satiety, or a feeling of fullness, and lead ... a fruit drink. The,milk drinkers ate about 50 fewer calories ...
... Personalized Medicine Meeting Elicits Varying Perspectives , , WASHINGTON, ... to regulate genetic testing is problematic, according to a recent ... of the attendees at a colloquium on personalized medicine, sponsored ... American Association for the Advancement of Science (AAAS) responded "yes" ...
... to attend field hearing exploring use of Recovery Act funds ... Senator Benjamin L. Cardin (D-MD ), chaired a field hearing ... Entrepreneurship in Rockville, MD, entitled " Missed Opportunities: The ... local and national experts in biotechnology testified about the important ...
... Center,s two camps, Camp Courage in Maple Lake and Courage North ... people with disabilities. , , A recent Muscular Dystrophy camp ... MDA staff) who tested positive for H1N1 flu (also known as ... officials were contacted by the MDA locally three days after the ...
Cached Medicine News:Health News:New Study Says Purported Melanoma Epidemic is Vastly Overstated 2Health News:Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 3Health News:Cardin Calls on NIH to Utilize Small Businesses for Extramural Research Projects 2Health News:Courage Camps Maintain Summer Camp Schedule for Children and Adults With Disabilities 2
(Date:9/2/2015)... YORK , Sept. 2, 2015   About ... the most common laboratory technologies that is used for ... antibodies in solution. ELISA test uses various types of ... phosphatases and the result is detected by photometry or ... the treatment of various infectious diseases such as HIV, ...
(Date:9/2/2015)... Calif. , Sept. 2, 2015 STAAR Surgical ... marketer of implantable lenses and delivery systems for the eye, ... William P. Wall to the Company,s Board. ... Capital, a Boston -based investment firm, for ... of the Board of Directors, and chair of the Corporate ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has announced ... UK - November 19-20, 2015)" conference to their ... cover industry case studies, regulatory updates, latest therapies and ... Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar Pharma ...
Breaking Medicine Technology:Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3William P. Wall Appointed to STAAR Surgical Board of Directors 2
Rapid Test Kit...
... Advanced Vision Information System) is an open ... on a platform designed to communicate and ... network can be expanded in various ways, ... Nidek products but also to fundus cameras ...
... laser photocoagulators includes the OcuLight SL and ... as a single laser source for multiple ... maintenance or special electrical/cooling, and allow easy ... SLx is now available with Tri-Mode capability ...
The simplest, most accurate Ortho-K lens fitting system ever!...
Medicine Products: